GBI Biomanufacturing and Allterum Therapeutics Announce Strategic Collaboration to Manufacture Therapeutic Antibody for Clinical Trials
Experience.
History-Making.
GBI Secures Commercial Manufacturing Contract, Solidifying Leadership in Radiopharmaceutical Manufacturing
JPM 2025 43rd Annual Healthcare Conference
January 13-16, 2025 The Westin St. Francis Hotel335 Powell St.
San Francisco
CA, 94102
The Improvements of the Production and Stability of a mAb-Chelator Conjugate by Modified Transchelation Conditions
Aseptic Vial Filling for Sterile Injectables: Ensuring Compliance in Drug Manufacturing
GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for Drug Products
Revolutionizing IND Filings with Rapid Analytics: Streamlined Platform Strategies for Faster and Safer Biopharmaceutical Development
Scaling Strategies in Drug Product Process Development: From Laboratory to Commercial Production
Innovation in Bispecific and Multi-Specific Antibody Engineering
DoE for Clone Selection and Process Development to Meet Biosimilar Critical Qualities Attributes and High Productivity
